The Greenrose Holding Company Inc. (GNRS) Research

Established in 2014 and headquartered in Amityville, New York, The Greenrose Holding Company Inc. operates via its subsidiaries to manufacture and distribute cannabis products. Its core business involves the cultivation, processing, and packaging of medical cannabis and related derivative items.

Market snapshot

Symbol
GNRS
Price
$0.00
Day change
-50.00%
Market cap
$1.8K
P/E ratio
0.00x
52-week range
1.0E-4-0.2825
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Beleave Inc. (BLEVF)
  • EPIRUS Biopharmaceuticals, Inc. (EPRSQ)
  • Global WholeHealth Partners Corporation (GWHP)
  • Integrated Pharmaceuticals, Inc. (INTP)
  • MEDirect Latino, Inc. (MLTO)
  • Orchid Ventures, Inc. (ORVRF)
  • RxElite, Inc. (RXEI)
  • Tauriga Sciences, Inc. (TAUG)

Recent insider activity

  • Wang Bernard — trade (131887 shares) on 2022-08-08
  • ROSE BENJAMIN — trade (0 shares) on 2022-08-05
  • Megale Thomas J — trade (0 shares) on 2022-06-07
  • Stegner Jeffrey — trade (0 shares) on 2021-12-22
  • Megale Thomas J — A-Award (22480 shares) on 2022-02-18

Open The Greenrose Holding Company Inc. (GNRS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.